Finance Home - My Yahoo - Yahoo! - Help

Monday, November 9, 2009, 11:27PM ET - U.S. Markets Closed. Dow  2.03% Nasdaq  1.97%

Enzon Pharmaceuticals Inc. (ENZN)

At 4:00PM ET: 9.83   0.85 (9.47%)

MORE ON ENZN

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Today, Mon, Nov 9, 2009 • ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Mon 2:43pm) • Enzon sells specialty drug business for $300M AP (Mon 11:18am) • UPDATE - Enzon to sell specialty pharma unit at Reuters (Mon 9:19am) • Enzon to sell specialty pharmaceuticals business at MarketWatch (Mon 8:47am) • Enzon Announces Agreement to Sell Specialty Pharmaceutical Business Business Wire (Mon 8:30am) • InPlay: Enzon trading halted - news pending Briefing.com (Mon 8:28am) Sat, Nov 7, 2009 • ENZON PHARMACEUTICALS INC Financials EDGAR Online Financials (Sat, Nov 7) Wed, Nov 4, 2009 • New Star Analyst Rankings for Enzon Pharmaceuticals, Inc. StarMine (Wed, Nov 4) Tue, Nov 3, 2009 • ENZON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online (Tue, Nov 3) • Enzon Reports Third Quarter 2009 Results Business Wire (Tue, Nov 3) • Q3 2009 Enzon Pharmaceuticals, Inc. Earnings Release - 08:00 am ET CCBN (Tue, Nov 3) Wed, Oct 28, 2009 • Enzon to Release Third Quarter 2009 Earnings on Tuesday, November 3, 2009; Conference Call and Webcast to Follow Business Wire (Wed, Oct 28) Thu, Oct 8, 2009 • European Approval for Cimzia Zacks.com (Thu, Oct 8) • 15 Breakout Stocks on Huge Volume at Seeking Alpha (Thu, Oct 8) Tue, Oct 6, 2009 • UCB's Cimzia®, the Only PEGylated Anti-TNF, Approved in Europe Business Wire (Tue, Oct 6) Mon, Oct 5, 2009 • PEGINTRON® Receives a Recommendation for Approval from FDA Advisory Committee for a New Application in Melanoma Business Wire (Mon, Oct 5) Wed, Sep 23, 2009 • BioMarin Begins Mid-Stage Trial Zacks.com (Wed, Sep 23) Thu, Sep 10, 2009 • Enzon to Present at Newsmakers in the Biotech Industry Conference Business Wire (Thu, Sep 10) Wed, Aug 5, 2009 • ENZON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Wed, Aug 5) Tue, Aug 4, 2009 • ENZON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online (Tue, Aug 4) Older Headlines - Download Recent Headlines View headlines from: Tue, Aug 4, 2009Tue, Jul 28, 2009Tue, Jul 21, 2009Tue, Jul 14, 2009Tue, Jul 7, 2009Tue, Jun 30, 2009Tue, Jun 23, 2009Tue, Jun 16, 2009Tue, Jun 9, 2009Tue, Jun 2, 2009 Add ENZN News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage